Showing results (281-290 of 341) with videos related to

Sort By:
Pageof 35
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 1998
Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?J G van der Bom, M P de Maat, M L Bots, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Constipation as an adverse effect of drug use in nursing home patients: an overestimated riskK N van Dijk, C S de Vries, P B van den Berg, et al.
AIDS (London, England)|November 23, 2000
Cost effectiveness of expanded antenatal HIV testing in LondonM J Postma, E J Beck, C A Hankins, et al.
Journal of Reconstructive Microsurgery|September 8, 2022
Neuropathic Donor-Site Pain following Radial Forearm Free Flap Harvest: A Multicenter Study on Incidence, Prognostic Factors, and Quality of LifeL L Bruin, C A Hundepool, L S Duraku, et al.
The American Journal of Pathology|October 1, 1995
Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanomaC M Mooy, G P Luyten, P T de Jong, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2024
High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providersJoost G E Verbeek, Leyla Azarang, Luis E Pilli, et al.
BMC Microbiology|November 2, 2012
Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtypeBrian H Raphael, Matthew Lautenschlager, Suzanne R Kalb, et al.
Pharmacy World & Science : PWS|June 25, 1999
Prescription data as a tool in pharmacotherapy audit (II). The development of an instrumentC S de Vries, P B van den Berg, J W Timmer, et al.
Annals of Internal Medicine|August 15, 1996
Reduced response to activated protein C is associated with increased risk for cerebrovascular diseaseJ G van der Bom, M L Bots, F Haverkate, et al.
Pageof 35